You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

The Leukocyte in Cardiovascular Disease Conference

Start date
January 27, 2011
End date
January 28, 2011
Venue
Forum Geneve
Location
Geneva, Switzerland
Topics
Cytokines; Chemokines; M1/M2 monocytes/macrophages; Lymphocytes; Dendritic cells; Atherosclerosis; Immunity; Transcription factors and Signaling

Event Summary

Organized by Beat Imhof, François Mach, and Abcam, the Leukocyte in Cardiovascular Disease conference brought together researchers from around the world to listen to the latest news, discuss developments and share ideas.

More than 150 delegates attended the conference which took place in Geneva, Switzerland. The conference program consisted of four sessions containing 24 talks from invited speakers and those selected from submitted abstracts plus a dedicated poster session during which 35 posters were presented.

Abcam always encourages networking at our events and to aid attendee interaction a conference social was held at the Edelweiss Restaurant where delegates sampled swiss fondues (cheese and meat) and listened to live traditional swiss music.

              
       
     

Description

Immune cells and their secreted factors have a large influence on cardiovascular pathologies. This conference will highlight the molecular role of myeloid cells and lymphocytes in atherogenesis and talks will be given by leading specialists in the field. Atheromas are dynamic lesions of dysfunctional endothelial and smooth muscle cells driven by infiltrating inflammatory monocyte/macrophages, mast cells or lymphocytes. The recent observations of possible anti-inflammatory roles of immune cell subpopulations and potential therapeutical interventions will be discussed.